Videobibliotek inom typ 2-inflammation, svår astma och Dupixent

Inspelade webbinar och videos

Här har du, som arbetar med respiratoriska sjukdomar och i synnerhet astma, möjlighet att djupdyka inom det ämne som intresserar just dig. Videomaterialet omfattar terpiområdesinformation inom relevanta områden, informationsvideos, patientberättelser etc. Presentatörerna är svenska och internationella opinionsledare, varför vissa videos är på svenska och andra på engelska.

Biomarkörer – målet med precionsmedicin vid astma

Professor Alving ger en bakgrund till biomarkörer vid astma och deras relevans i förhållande till sjukdomsaktivitet och Professor Bjermer tar upp biomarkörernas roll vid biologisk behandling av svår astma.

Severe asthma in children - Burden of disease and treatment options Dupilumab as a treatment for children 6-11 years with severe asthma

Speaker: Leonard B. Bacharier, MD Professor of Pediatrics, Janie Robinson and John Moore Lee Chair in Pediatrics, Vanderbilt University Medical Center Nashville, Tennessee, United States

Clinical utility of fractional exhaled nitric oxide (FeNO) in severa asthma management

RespTalks

The natural history of lung function in Asthma and COPD

Speaker: Yunus Çolak, MD, PhD, DMSc

The Finnish Allergy Programme shows the new direction

Speaker: Tari Haahtela

Mucus plugging: biology and effects in the airways

Speaker: Professor Bart Lambrecht

Redefining Pediatric Severe Asthma & the Future of Clinical Management

Speaker: Professon Adnan Custovic

Blood esinophils, FeNO, and the modifiable risk of asthma attacks

Speaker: Simon Coulliard, MD

Treatable traits and risk prediction in asthma

Speaker: Speaker: Professor Ian Pavord and Simon Coulliard, MD

Documentary series Respiratory Around

Episode 2: The Type 2 Experience: Exploring the Clinical Burden and Underlying Type 2 Inflammation in Severe Asthma Patients

Professor Ian Pavord, UK, takes a close look at the clinical burden of uncontrolled severe asthma and the enhanced burden in patients with coexisting type 2 inflammatory diseases.

Professor Andrea Matucci, Italy, elucidates the mechanisms of type 2 inflammation underpinning the pathophysiology and clinical outcomes in patients with uncontrolled asthma.

Episode 3: CRSwNP, A Type 2 Inflammatory Disease: Past, Present, and Future Perspectives

Dr. Stella Lee, US, describes the key role of type 2 inflammation in the pathophysiology of CRSwNP with an exploration of the key epithelial barrier and gene changes associated with type 2 inflammation.

Professor Martin Wagenmann, Germany, describes the chronic clinical burden and the burden of standard of care in patients with CRSwNP, including a discussion of the role of type 2 comorbidities.

Episode 4: Collaborative Management of Type 2 Inflammation in Patients With Asthma and CRSwNP

Professor Eric Bateman, South Africa, takes a patient-focused approach to the management of type 2 inflammation in uncontrolled severe asthma with a review of recent long-term biologic efficacy.

Professor Peter Hellings, Belgium, leads a spirited discussion of the role of type 2 inflammation in the pathophysiology of CRSwNP, including the latest data supporting the role of biologics in addressing type 2 inflammation in CRSwNP, from the perspective of an ENT.

10 frågor om....

Tio frågor om Typ 2-inflammation

ställda till Dr Leif Bjermer

Dupixent minimiinformation